Literature DB >> 29654837

Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.

Anna M Seekatz1, Casey M Theriot1, Krishna Rao1, Yu-Ming Chang2, Alison E Freeman2, John Y Kao2, Vincent B Young3.   

Abstract

A significant proportion of individuals develop recurrent Clostridium difficile infection (CDI) following initial disease. Fecal microbiota transplantation (FMT), a highly effective treatment method for recurrent CDI, has been demonstrated to induce microbiota recovery. One of the proposed functions associated with restoration of colonization resistance against C. difficile has been recovery of bile acid metabolism. In this study, we aimed to assess recovery of short chain fatty acids (SCFAs) in addition to bile acids alongside microbial community structure in six patients with recurrent CDI following treatment with FMT over time. Using 16S rRNA gene-based sequencing, we observed marked similarity of the microbiota between recipients following FMT (n = 6, sampling up to 6 months post-FMT) and their respective donors. Sustained increases in the levels of the SCFAs butyrate, acetate, and propionate were observed post-FMT, and variable recovery over time was observed in the secondary bile acids deoxycholate and lithocholate. To correlate these changes with specific microbial taxa at an individual level, we applied a generalized estimating equation approach to model metabolite concentrations with the presence of specific members of the microbiota. Metabolites that increased following FMT were associated with bacteria classified within the Lachnospiraceae, Ruminococcaceae, and unclassified Clostridiales families. In contrast, members of these taxa were inversely associated with primary bile acids. The longitudinal aspect of this study allowed us to characterize individualized patterns of recovery, revealing variability between and within patients following FMT.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bile acids; Fecal microbiota transplantation; Gut microbiota; Human microbiome; Short chain fatty acids

Mesh:

Substances:

Year:  2018        PMID: 29654837      PMCID: PMC6185828          DOI: 10.1016/j.anaerobe.2018.04.001

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  43 in total

1.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

Authors:  Ju Young Chang; Dionysios A Antonopoulos; Apoorv Kalra; Adriano Tonelli; Walid T Khalife; Thomas M Schmidt; Vincent B Young
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

Review 3.  Bile salt biotransformations by human intestinal bacteria.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2005-11-18       Impact factor: 5.922

Review 4.  Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.

Authors:  Giovanni Cammarota; Gianluca Ianiro; Antonio Gasbarrini
Journal:  J Clin Gastroenterol       Date:  2014-09       Impact factor: 3.062

5.  Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.

Authors:  Alexa R Weingarden; Chi Chen; Aleh Bobr; Dan Yao; Yuwei Lu; Valerie M Nelson; Michael J Sadowsky; Alexander Khoruts
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-27       Impact factor: 4.052

6.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

Authors:  Luying Peng; Zhong-Rong Li; Robert S Green; Ian R Holzman; Jing Lin
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

7.  Durable coexistence of donor and recipient strains after fecal microbiota transplantation.

Authors:  Simone S Li; Ana Zhu; Vladimir Benes; Paul I Costea; Rajna Hercog; Falk Hildebrand; Jaime Huerta-Cepas; Max Nieuwdorp; Jarkko Salojärvi; Anita Y Voigt; Georg Zeller; Shinichi Sunagawa; Willem M de Vos; Peer Bork
Journal:  Science       Date:  2016-04-29       Impact factor: 47.728

8.  Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.

Authors:  Oliver A Cornely; Mark A Miller; Thomas J Louie; Derrick W Crook; Sherwood L Gorbach
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

9.  Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

Authors:  Charlie G Buffie; Vanni Bucci; Richard R Stein; Peter T McKenney; Lilan Ling; Asia Gobourne; Daniel No; Hui Liu; Melissa Kinnebrew; Agnes Viale; Eric Littmann; Marcel R M van den Brink; Robert R Jenq; Ying Taur; Chris Sander; Justin R Cross; Nora C Toussaint; Joao B Xavier; Eric G Pamer
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

10.  Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Yang Song; Shashank Garg; Mohit Girotra; Cynthia Maddox; Erik C von Rosenvinge; Anand Dutta; Sudhir Dutta; W Florian Fricke
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more
  57 in total

1.  The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent Clostridioides difficile infections in Germany.

Authors:  Rosemarie Peri; Rebeca Cruz Aguilar; Kester Tüffers; Andreas Erhardt; Alexander Link; Philipp Ehlermann; Wolfgang Angeli; Thorsten Frank; Martin Storr; Thomas Glück; Andreas Sturm; Ulrich Rosien; Frank Tacke; Oliver Bachmann; Philipp Solbach; Andreas Stallmach; Felix Goeser; Maria Jgt Vehreschild
Journal:  United European Gastroenterol J       Date:  2019-03-21       Impact factor: 4.623

2.  The need to move away from fecal transplant towards targeted, refined microbiome therapy.

Authors:  Lindsey Russell; Tanya Monaghan; Dina Kao
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 3.  The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens.

Authors:  Kevin S Gipson; Kourtney P Nickerson; Eliana Drenkard; Alejandro Llanos-Chea; Snaha Krishna Dogiparthi; Bernard B Lanter; Rhianna M Hibbler; Lael M Yonker; Bryan P Hurley; Christina S Faherty
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 4.  Recipient factors in faecal microbiota transplantation: one stool does not fit all.

Authors:  Camille Danne; Nathalie Rolhion; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-04-27       Impact factor: 46.802

5.  Measurement of Short-Chain Fatty Acids in Respiratory Samples: Keep Your Assay above the Water Line.

Authors:  Min Yue; Jae Hyun Kim; Charles R Evans; Maureen Kachman; John R Erb-Downward; Jennifer D'Souza; Betsy Foxman; Sara D Adar; Jeffrey L Curtis; Kathleen A Stringer
Journal:  Am J Respir Crit Care Med       Date:  2020-08-15       Impact factor: 21.405

6.  Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of Clostridioides difficile infection.

Authors:  Julie Reygner; Christine Charrueau; Johanne Delannoy; Camille Mayeur; Véronique Robert; Céline Cuinat; Thierry Meylheuc; Aurélie Mauras; Jérémy Augustin; Ioannis Nicolis; Morgane Modoux; Francisca Joly; Anne-Judith Waligora-Dupriet; Muriel Thomas; Nathalie Kapel
Journal:  Gut Microbes       Date:  2020-06-05

Review 7.  Microbe-microbe interactions during Clostridioides difficile infection.

Authors:  Arwa Abbas; Joseph P Zackular
Journal:  Curr Opin Microbiol       Date:  2020-02-20       Impact factor: 7.934

Review 8.  Fecal Microbiota Transfer.

Authors:  Andreas Stallmach; Arndt Steube; Philip Grunert; Michael Hartmann; Lena M Biehl; Maria J G T Vehreschild
Journal:  Dtsch Arztebl Int       Date:  2020-01-17       Impact factor: 5.594

9.  Human fecal metabolomic profiling could inform Clostridioides difficile infection diagnosis and treatment.

Authors:  Casey M Theriot; Joshua R Fletcher
Journal:  J Clin Invest       Date:  2019-08-12       Impact factor: 14.808

10.  Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.

Authors:  John I Robinson; William H Weir; Jan R Crowley; Tiffany Hink; Kimberly A Reske; Jennie H Kwon; Carey-Ann D Burnham; Erik R Dubberke; Peter J Mucha; Jeffrey P Henderson
Journal:  J Clin Invest       Date:  2019-08-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.